The Society of Hematologic Oncology (SOHO) Annual Meeting 2020, 9-12 September, will see hematology experts from around the world congregate virtually to communicate high-quality content focusing on the latest information for practitioners and scientists in the field.

Highlights from this year’s SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

View all videos

SOHO 2020

Society of Hematologic Oncology (SOHO) Annual Meeting 2020
09–12 September 2020 | Houston, Texas, USA

We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:

🎥: http://ow.ly/GGiK50KVRjM

#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022

We had a great interview with Catherine Coombs of @UNC, who shared some insights into novel BTK inhibitors in CLL and future outlooks.

@SocietyofHemOnc #SOHO22 #HemOnc #LeuSM #CLLsm

#SOHO22 | Peter Valk (@ErasmusMC) discusses TP53-mutated AML and MDS, the prognostic value of FLT3-ITD residual disease in AML, and more.

Visit http://VJHemOnc.com for our interviews from this year's meeting!

#SOHO2022 #HemOnc #LeuSM #AMLsm #MDSsm

At #SOHO22: Our Dr. Robert Orlowski discusses early data in bispecific T cell engagement for treatment of multiple myeloma. @Myeloma_Doc #EndCancer

Load More...

SOHO 2020

Society of Hematologic Oncology (SOHO) Annual Meeting 2020
09–12 September 2020 | Houston, Texas, USA

The Society of Hematologic Oncology (SOHO) Annual Meeting 2020, 9-12 September, will see hematology experts from around the world congregate virtually to communicate high-quality content focusing on the latest information for practitioners and scientists in the field.

Highlights from this year’s SOHO Annual Meeting include clinical updates on leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas and other related malignancies.

View all videos

We spoke to @adamssperling (@DanaFarber), who shared some insights into the role of clonal hematopoiesis in multiple myeloma and other hematological malignancies:

🎥: http://ow.ly/GGiK50KVRjM

#MMsm #HemOnc #BloodCancerAwarenessMonth #IMS2022

We had a great interview with Catherine Coombs of @UNC, who shared some insights into novel BTK inhibitors in CLL and future outlooks.

@SocietyofHemOnc #SOHO22 #HemOnc #LeuSM #CLLsm

#SOHO22 | Peter Valk (@ErasmusMC) discusses TP53-mutated AML and MDS, the prognostic value of FLT3-ITD residual disease in AML, and more.

Visit http://VJHemOnc.com for our interviews from this year's meeting!

#SOHO2022 #HemOnc #LeuSM #AMLsm #MDSsm

At #SOHO22: Our Dr. Robert Orlowski discusses early data in bispecific T cell engagement for treatment of multiple myeloma. @Myeloma_Doc #EndCancer

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter